Search

everythinglearnresearchcommunity

for

Search:↓

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Some chemotherapy can cause permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Certain drugs that block specific enzymes can help treat prostate diseases.

Low-level laser treatment helped rats regrow hair faster after chemotherapy.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Finasteride may improve prostate cancer treatment outcomes.

People undergoing chemotherapy need better support and information to cope with hair loss.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Dutasteride and finasteride affect different cell types differently.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

PHAT may improve hair growth better than PRP alone.